Study reveals that a quarter of men with low-volume intermediate-risk prostate cancer had adverse pathologic features found at radical prostatectomy.
Randomized trial found no significant difference in all-cause and cancer-specific survival between radical prostatectomy and observation for localized prostate cancer.
Over a 10-year period, radical prostatectomy use increased steadily while radiotherapy use declined
Younger patients who chose surgery vs radiation for initial treatment had a 48% survival advantage.
Urinary incontinence and diminished sexual function were common after a median follow-up of nearly 15 years, study finds.
Overall complication rates were similar between primary and salvage RARP groups, but there were some notable differences in prognosis.
Pathologic Gleason scores, positive surgical margin rates, and PSA doubling times differentiate earlier from later biochemical recurrence after radical surgery.
Patients with longer hospital stays and pre-discharge complications were at increased risk of readmission within 30 days of discharge.
Researchers found no evidence of worse cancer outcomes with nerve-sparing surgery.
Study compared PCa patients who underwent surgery or radiation treatment with a matched group of non-cancer controls.
No benefit of autologous urethral sling placement at robotic assisted radical prostatectomy on early return of continence at 6 months.
The pooled estimate for the overall attrition prevalence was 18%, with significant variation between studies.
Obesity predicts a wider range of complications in PCa patients who undergo laparoscopic or robot-assisted versus open radical prostatectomy.
Over a median follow-up of 70 months, 15% of men studied experienced biochemical recurrence.
Within each D'Amico risk category, African-American and Hispanic prostate cancer patients were less likely to receive definitive treatment than white patients.
Ten-year mortality rates of prostate cancer are low, regardless of whether patients are treated with radiotherapy, surgery, or undergo only active surveillance.
Large prostates and bladder neck sparing also predict longer time to return of continence.
Radiation therapy also is associated with a greater likelihood of fractures.
Many men are unaware of erectile function recovery time and problems with ejaculation.
Modified technique improved stress urinary incontinence in nearly three-quarters of patients.
No significant association found between phosphodiesterase type 5 inhibitor use and biochemical recurrence after radical treatment.
In a study of patients aged 59 years or younger, cancer-specific and other-cause mortality rates at 20 years were 13.5% and 19.3%, respectively.
Men with clinically-localized tumors are more likely to die from any cause or from PCa if they undergo radiotherapy rather than radical prostatectomy, study finds.
New analysis shows no significant difference in 10-year progression-free and overall survival among men with high-risk prostate cancer.
Large cost variation over 12 years of follow-up due to equipment, visits.
Radical prostatectomy was associated with a higher biochemical recurrence-free survival rate compared with radiotherapy.
Problems include longer waits, greater need for more care after surgery, and rehospitalization.
After 2 years, continence, potency, and freedom from recurrence were achieved in almost half of men who had extended pelvic lymph node dissection.
Biochemical failure rates, however, appear to be better with radiation, single-institution study finds.
Renal and Urology News Articles
- For Treating Uremic Pruritus, Evidence is Strongest for Gabapentin
- IgG-Degrading Enzyme Desensitizes, Permits HLA-Incompatible Transplant
- Evaluating Practice Options in the Shifting Health Care Landscape
- Melanoma Risk Higher in Kidney Transplant Recipients
- Kidneys From Octogenarian Donors Show Similar Survival
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)